An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A hair-care company called Neurogan Health is promoting a serum built around a peptide called GHK-Cu and one other ingredient. The ad or article claims customers are seeing real improvements in hair thickness, growth, and scalp health. The story is mainly about a product launch and customer reactions, not a new clinical trial. GHK-Cu is a short chain of amino acids (a peptide) that naturally occurs in the body and can bind copper (that’s the “-Cu” part). In simple terms, it’s a tiny molecule your skin and scalp can recognize. Companies market it for skin repair and hair health because laboratory studies suggest it can influence processes like inflammation and tissue remodeling. That doesn’t mean it’s a miracle — it’s a biochemical cue that can nudge cells in certain directions under the right conditions. The coverage here appears to focus on user testimonials and before-and-after photos rather than on large, controlled human studies. Some published research—mostly in cells or animals, and a few small human trials for skin—reports promising biological effects of GHK-Cu, but robust, large-scale clinical evidence for hair regrowth in broad populations is limited. So when a company shows dramatic customer photos, remember those are anecdotal: they may reflect real benefits for some people, but they aren’t the same as proof that the product works consistently for everyone. Why this matters is practical. Hair thinning and scalp issues are common and emotionally impactful problems. If a topical product with a peptide can safely improve hair quality for some users, that could expand options beyond current drugs and cosmetic fixes. People looking for non-prescription, topical treatments may be curious to try such serums, especially if they prefer gentler or more "biotech-y" approaches than traditional chemicals. There are important caveats. Topical peptides can be expensive and their absorption through the scalp varies. Skin reactions are possible, so patch testing is wise. Products differ in concentration, formulation, and manufacturing quality, and marketing claims can outpace scientific backing. Also, regulatory oversight for cosmetics and many over-the-counter serums is weaker than for prescription medicines, so clinical claims should be read carefully. If someone has a medical cause for hair loss (like hormonal issues or autoimmune disease), they should consult a clinician before relying on a cosmetic serum. Bottom line: GHK-Cu–based serums are an interesting, science-derived option that might help some people’s hair and scalp, but current public claims rely more on customer stories than on definitive large-scale clinical proof.
Source: Morningstar